Mesoblast Ltd
MSB
Company Profile
Business description
Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.
Contact
Level 38, 55 Collins Street
Melbourne VIC 3000
AUST: +61 396396036
E: michael.schuster@mesoblast.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
83
Mesoblast Ltd News & Analysis
stocks
Shorts circle BHP ahead of listing unification: ASX’s most shorted stocks
Morningstar analysts see value in several stocks under fire from shorts.
stocks
The most shorted stocks in Australia
The covid effect, poor results, and trade tensions with China have sharpened short-seller interest in a number of Australian companies.
stocks
Mayne Pharma woes to persist for 2020
Morningstar had forecast big losses for the drugmaker, which has been dropped from the ASX 200.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,244.90 | 17.50 | -0.21% |
CAC 40 | 7,632.71 | 91.61 | -1.19% |
DAX 40 | 18,590.89 | 157.29 | -0.84% |
Dow JONES (US) | 40,211.72 | 210.82 | 0.53% |
FTSE 100 | 8,182.96 | 69.95 | -0.85% |
HKSE | 17,752.05 | 263.89 | -1.46% |
NASDAQ | 18,472.57 | 74.12 | 0.40% |
Nikkei 225 | 41,338.09 | 147.41 | 0.36% |
NZX 50 Index | 12,110.47 | 12.67 | -0.10% |
S&P 500 | 5,631.22 | 15.87 | 0.28% |
S&P/ASX 200 | 7,997.80 | 19.80 | -0.25% |
SSE Composite Index | 2,963.25 | 10.76 | -0.36% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Droneshield Ltd DRO | 2.41 | 0.19 | -7.31% |
Bellevue Gold Ltd BGL | 1.86 | 0.07 | -3.63% |
Latin Resources Ltd LRS | 0.16 | 0.01 | -7.35% |
Red 5 Ltd RED | 0.42 | 0.00 | -0.60% |
Core Lithium Ltd CXO | 0.11 | 0.01 | -6.25% |
Zip Co Ltd ZIP | 1.61 | 0.04 | 2.22% |
Australian Vanadium Ltd AVL | 0.02 | 0.00 | 0.00% |
Tabcorp Holdings Ltd TAH | 0.68 | 0.01 | -1.80% |
Imugene Ltd IMU | 0.06 | 0.00 | 0.00% |
Mirvac Group MGR | 2.09 | 0.01 | 0.48% |